Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 9, 2000, Pages 889-894

  Goldstein, A M ^a   Martinez, M ^a   Tucker, M A ^a   Demenais, F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CHILD; CHROMOSOME 9P; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPLASTIC NEVUS; FAMILIAL DISEASE; GENETIC LINKAGE; GENETIC RISK; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL MODEL;

ADOLESCENT; ADULT; DYSPLASTIC NEVUS SYNDROME; FAMILY HEALTH; GENES, P16; HUMANS; LIKELIHOOD FUNCTIONS; LINKAGE (GENETICS); LOGISTIC MODELS; MELANOMA; MIDDLE AGED; MODELS, GENETIC; MUTATION; NEVUS; ODDS RATIO; RISK FACTORS; SKIN NEOPLASMS; UNITED STATES;

EID: 0033796298     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Individuals at high risk of melanoma
2. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
3. A p16(INK4a)-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
4. Germline mutations in the p16(INK4a) binding domain of CDK4 in familial melanoma
5. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France
6. Cutaneous malignant melanoma
7. Clinically recognized dysplastic nevi: A central risk factor for cutaneous melanoma
8. Sun-related risk factors in melanoma-prone families with CDKN2A mutations
9. Clinical and epidemiologic factors in melanoma-prone families with p16 mutations
10. Regression logistic models for familial disease and other binary traits
11. Combined linkage and segregation analysis using regressive models
12. REGRESS: A computer program including the regressive approach into the LINKAGE programs
13. Germline p16 mutations in familial melanoma
14. A time-dependent logistic hazard function for modeling variable age of onset in analysis of familial diseases
15. Easy calculation of LOD scores and genetic risks on small computers
16. Interactions between genetic and reproductive factors in breast cancer risk in a French family sample
17. Infrequent mutation of p16(INK4) in sporadic melanoma
18. Further evidence for ultraviolet light induction of CDKN2 (p16(INK4)) mutations in sporadic melanoma in vivo
19. Abnormalities in the CDKN2 (p16(INK4)/MTS-1) gene in human melanoma cells: Relevance to tumor growth and metastasis
20. Evidence for U.V. induction of CDKN2 mutations in melanoma cell lines
21. Oncogenes and tumor suppressor genes in cutaneous malignant melanoma
22. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families
23. Re: The atypical mole syndrome and predisposition to melanoma
24. A critical look at methods for handling missing covariates in epidemiologic regression analyses
25. Detection of gene-environment interactions in joint segregation and linkage analysis
26. Censored survival models for genetic epidemiology: A Gibbs sampling approach
27. Analysis of gene-smoking interaction in lung cancer
28. Segregation analysis incorporating linkage markers. I. Single-locus models with an application to type 1 diabetes
29. Lods, Wrods, and Mods. The interpretation of Lod scores calculated under different models
30. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM)
31. Interactions between genetic and epidemiological risk factors in cutaneous malignant melanoma in France